Calamos Advisors LLC Merck & Co., Inc. Transaction History
Calamos Advisors LLC
- $16.8 Billion
- Q4 2024
A detailed history of Calamos Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 852,847 shares of MRK stock, worth $83.8 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
852,847
Previous 953,704
10.58%
Holding current value
$83.8 Million
Previous $108 Million
21.66%
% of portfolio
0.51%
Previous 0.67%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,815Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.45 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.81 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...